Zhuhai Rundu Pharmaceutical Co., Ltd.
SZSE:002923.SZ
12.55 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 213.859 | 221.032 | 250.302 | 251.682 | 197.824 | 182.501 | 168.095 | 149.529 | 104.576 | 92.487 | 82.556 | 86.079 | 61.103 |
Short Term Investments
| 0.052 | 0.062 | 0.087 | 44.011 | -19.617 | -10.392 | -14.675 | -10.847 | -10.641 | -3.405 | -3.715 | 0 | 0 |
Cash and Short Term Investments
| 213.912 | 221.093 | 250.389 | 295.693 | 197.824 | 182.501 | 168.095 | 149.529 | 104.576 | 92.487 | 82.556 | 86.079 | 61.103 |
Net Receivables
| 212.112 | 226.959 | 186.115 | 171.034 | 203.878 | 143.168 | 114.899 | 91.694 | 84.282 | 71.245 | 55.012 | 49.414 | 52.514 |
Inventory
| 415.455 | 440.855 | 335.527 | 302.002 | 239.651 | 171.114 | 122.827 | 83.148 | 63.381 | 52.617 | 67.953 | 48.796 | 33.965 |
Other Current Assets
| 4.035 | 57.338 | 36.105 | 9.056 | 139.747 | 277.973 | 1.641 | 0.517 | -3.917 | -3.849 | 0 | -2.911 | -3.427 |
Total Current Assets
| 866.733 | 946.246 | 808.137 | 777.785 | 781.099 | 774.755 | 407.462 | 324.888 | 248.322 | 212.501 | 205.521 | 181.378 | 144.155 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 1,249.617 | 1,223.722 | 972.572 | 581.993 | 440.442 | 309.38 | 248.418 | 252.666 | 209.251 | 128.886 | 101.077 | 78.075 | 63.402 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.988 | 0.988 |
Intangible Assets
| 66.053 | 67.616 | 68.997 | 65.475 | 50.115 | 22.71 | 23.268 | 23.825 | 24.383 | 24.94 | 25.498 | 26.056 | 26.613 |
Goodwill and Intangible Assets
| 66.053 | 67.616 | 68.997 | 65.475 | 50.115 | 22.71 | 23.268 | 23.825 | 24.383 | 24.94 | 25.498 | 27.043 | 27.601 |
Long Term Investments
| 0.5 | 0.438 | 0.413 | -43.511 | 20.117 | 10.892 | 15.175 | 11.347 | 11.141 | 3.905 | 4.215 | 0.5 | 0 |
Tax Assets
| 10.673 | 10.229 | 8.614 | 11.645 | 9.343 | 5.273 | 7.473 | 2.611 | 2.219 | 2.096 | 1.945 | 2.095 | 1.528 |
Other Non-Current Assets
| 34.198 | 38.1 | 50.705 | 120.386 | 25.565 | 15.41 | 4.208 | 1.265 | 4.403 | 3.076 | 6.28 | 4.967 | 1.934 |
Total Non-Current Assets
| 1,361.04 | 1,340.104 | 1,101.301 | 735.988 | 545.581 | 363.665 | 298.542 | 291.716 | 251.397 | 162.904 | 139.015 | 112.68 | 94.465 |
Total Assets
| 2,227.774 | 2,286.35 | 1,909.438 | 1,513.772 | 1,326.68 | 1,138.42 | 706.004 | 616.603 | 499.719 | 375.405 | 344.536 | 294.058 | 238.62 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 153.792 | 213.413 | 152.497 | 91.34 | 46.184 | 18.85 | 22.432 | 38.412 | 30.385 | 11.656 | 13.087 | 12.51 | 9.874 |
Short Term Debt
| 131.472 | 89.966 | 35.524 | 67.15 | 18.186 | 17.96 | 37.96 | 33 | 43 | 29.6 | 29.6 | 20 | 20 |
Tax Payables
| 12.741 | 29.944 | 10.815 | 3.108 | 6.449 | 17.358 | 18.967 | 9.885 | 13.762 | 12.253 | 14.672 | 10.313 | 9.229 |
Deferred Revenue
| 153.592 | 46.684 | 217.779 | 200.6 | 210.091 | 17.358 | 34.099 | 21.17 | 23.986 | 19.738 | 21.82 | 18.243 | 17.052 |
Other Current Liabilities
| 7.456 | 239.678 | 17.068 | 1.69 | 19.41 | 96.496 | 17.612 | 16.409 | 11.904 | 12.791 | 13.031 | 13.936 | 10.17 |
Total Current Liabilities
| 446.312 | 589.741 | 422.868 | 360.779 | 293.872 | 150.664 | 112.103 | 108.991 | 109.275 | 73.785 | 77.538 | 64.689 | 57.095 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 441.351 | 378.461 | 251.082 | 2.226 | 11.346 | 29.306 | 47.266 | 80 | 50.4 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 157.571 | 120.985 | 119.736 | 109.212 | 81.168 | 87.156 | 57.795 | 29.425 | 29.322 | 28.314 | 30.712 | 29.942 | 0 |
Deferred Tax Liabilities Non-Current
| 2.309 | 0 | 0 | 0 | -11.346 | -29.306 | -47.266 | -80 | -50.4 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 1.072 | 1.178 | 3.596 | 3.321 | 11.346 | 29.306 | 47.266 | 80 | 50.4 | 0 | 0 | -0 | 16.194 |
Total Non-Current Liabilities
| 602.303 | 500.624 | 374.414 | 114.759 | 92.514 | 116.462 | 105.061 | 109.425 | 79.722 | 28.314 | 30.712 | 29.942 | 16.194 |
Total Liabilities
| 1,048.614 | 1,090.366 | 797.283 | 475.539 | 386.386 | 267.125 | 217.164 | 218.416 | 188.997 | 102.099 | 108.25 | 94.631 | 73.289 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 334.893 | 239.209 | 185.71 | 185.912 | 185.42 | 120 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
Retained Earnings
| 530.784 | 564.956 | 503.905 | 452.66 | 405.432 | 372.637 | 345.831 | 255.178 | 176.343 | 145.914 | 115.518 | 84.574 | 55.942 |
Accumulated Other Comprehensive Income/Loss
| 183.182 | 112.953 | 76.311 | 68.567 | 42.212 | 49.469 | 39.431 | 68.009 | 59.378 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 130.301 | 278.866 | 346.23 | 331.096 | 307.232 | 329.188 | 28.578 | 0 | 0 | 52.392 | 45.768 | 39.853 | 34.389 |
Total Shareholders Equity
| 1,179.159 | 1,195.984 | 1,112.156 | 1,038.234 | 940.295 | 871.295 | 488.84 | 398.187 | 310.721 | 273.306 | 236.286 | 199.427 | 165.331 |
Total Equity
| 1,179.159 | 1,195.984 | 1,112.156 | 1,038.234 | 940.295 | 871.295 | 488.84 | 398.187 | 310.721 | 273.306 | 236.286 | 199.427 | 165.331 |
Total Liabilities & Shareholders Equity
| 2,227.774 | 2,286.35 | 1,909.438 | 1,513.772 | 1,326.68 | 1,138.42 | 706.004 | 616.603 | 499.719 | 375.405 | 344.536 | 294.058 | 238.62 |